HF
GSK icon

Halpern Financial’s GSK GSK Stock Holding History

Halpern Financial’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-160
Closed -$8.82K – 242
2021
Q4 		$8.82K Buy
+160
New +$8.32K ﹤0.01% 191
2021
Q3 		– Sell
-171
Closed -$8.59K – 268
2021
Q2 		$8.52K Hold
171
– – ﹤0.01% 152
2021
Q1 		$7.64K Buy
+171
New +$7.76K ﹤0.01% 159

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Halpern Financial's GSK Position: Q1 2022 in Review

Halpern Financial sold out of GSK (GSK) in Q1 2022, closing a stake of 160 shares — an estimated $8.82K sold.

Halpern Financial first reported a position in GSK in Q1 2021 and held it in 3 quarters. The position peaked at $8.82K in Q4 2021. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

  • Halpern Financial reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
  • Halpern Financial sold 160 GSK shares in Q1 2022, an estimated $8.82K.
  • Halpern Financial first reported a position in GSK in Q1 2021 and held it in 3 quarters.
  • Halpern Financial's GSK position peaked at $8.82K in Q4 2021.
  • 929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Halpern Financial's 13F filing for Q1 2022, filed 21 Sep 2023.